Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

NOX5 is a therapeutic target in diabetic kidney disease

Oct. 9, 2020

Patient screening ongoing in phase IIa study of IP-2018

Oct. 6, 2020

CSL begins phase II study of CSL-346 in diabetic kidney disease

Oct. 2, 2020

Positive topline phase I data for ROSgard in patients with renal impairment

Sep. 30, 2020

Ultomiris approved in Japan for aHUS in adults and children

Sep. 29, 2020

Dimerix reports phase II data on DMX-200 in diabetic kidney disease

Sep. 14, 2020

Bayer initiates enrollment in phase II CONCORD study of runcaciguat

Sep. 10, 2020

First subject dosed in phase I study of ALLN-346

Sep. 9, 2020

Akebia reports topline data from its PRO2TECT global phase III program of vadadustat

Sep. 4, 2020

Tohoku University divulges dioxolan derivatives for renal diseases

Sep. 2, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...